Medtronic, Nile Therapeutics to work on drug-device combo

02/28/2011 | American City Business Journals

Medtronic has agreed to partner with Nile Therapeutics to develop a peptide drug, called cenderitide, for heart failure and renal disease that can be delivered by its diabetes pump system. Under the agreement, Nile will focus on conducting a first-stage trial of the peptide, and Medtronic will provide financing and share its knowledge in developing drug-device combination products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations